| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $1,126,155 ) |
| 2025 | 2025 | INVIVO BIOSYSTEMS, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44OD035388 | Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | 001 | 3 | NIH | 2/26/2025 | $1,126,155 |
| 2025 | 2023 | INVIVO BIOSYSTEMS, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44OD035388 | Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | 000 | 1 | NIH | 2/7/2025 | $0 |
| 2025 | 2022 | INVIVO BIOSYSTEMS, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43OD032090 | DanFreez: Zebrafish Genetically-Optimized for Cryogenic Storage of Embryos | 000 | 1 | NIH | 1/2/2025 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $1,586,288 ) |
| 2024 | 2024 | NEMAMETRIX, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43ES036386 | The ToxiFin Platform: Advancing High-Throughput Screening and Mechanistic Insights For Developmental Neurotoxicants Using the Zebrafish Model | 000 | 1 | NIH | 5/1/2024 | $296,420 |
| 2024 | 2024 | NEMAMETRIX, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44OD035388 | Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | 000 | 2 | NIH | 3/26/2024 | $1,289,868 |
| 2024 | 2020 | NEMAMETRIX, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 000 | 1 | NIH | 12/12/2023 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $388,772 ) |
| 2023 | 2023 | NEMAMETRIX, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44OD035388 | Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | 001 | 1 | NIH | 9/21/2023 | $0 |
| 2023 | 2023 | NEMAMETRIX, INC. | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44OD035388 | Improving Husbandry and Data Reproducibility Through Automated Health Monitoring in Zebrafish Facilities | 000 | 1 | NIH | 7/21/2023 | $388,772 |
| 2023 | 2022 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43OD032090 | DanFreez: Zebrafish Genetically-Optimized for Cryogenic Storage of Embryos | 000 | 1 | NIH | 11/1/2022 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $464,655 ) |
| 2022 | 2022 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43OD032090 | DanFreez: Zebrafish Genetically-Optimized for Cryogenic Storage of Embryos | 000 | 1 | NIH | 8/9/2022 | $464,655 |
| 2022 | 2021 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 001 | 1 | NIH | 4/6/2022 | $0 |
| 2022 | 2020 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 000 | 1 | NIH | 4/6/2022 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $124,932 ) |
| 2021 | 2021 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 000 | 1 | NIH | 12/9/2020 | $124,932 |
| 2021 | 2021 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 002 | 1 | NIH | 3/25/2021 | $0 |
| 2021 | 2020 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 001 | 1 | NIH | 3/25/2021 | $0 |
| 2021 | 2019 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R44GM119906 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | 000 | 3 | NIH | 9/4/2021 | $0 |
| 2021 | 2019 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43GM133229 | Humanized LMNA Animal Model for Detecting Pathogenicity in Clinical Variants | 000 | 1 | NIH | 9/4/2021 | $0 |
| 2021 | 2019 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43NS108847 | Resubmission: Systems for Exploring Pathogenicity in Clinical Variants of a Presynaptic Protein Involved in Epilepsy | 000 | 1 | NIH | 11/12/2020 | $0 |
| 2021 | 2018 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43AG061978 | Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia | 000 | 1 | NIH | 3/12/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $350,000 ) |
| 2020 | 2020 | NEMAMETRIX, INC | 1505 WESTEC DR | EUGENE | OR | 97402-9190 | LANE | USA | R43HG010852 | Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping. | 000 | 1 | NIH | 4/23/2020 | $350,000 |
|
 | Issue Date FY: 2019 ( Subtotal = $1,589,434 ) |
| 2019 | 2019 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R43GM133229 | Humanized LMNA Animal Model for Detecting Pathogenicity in Clinical Variants | 000 | 1 | NIH | 3/26/2019 | $225,000 |
| 2019 | 2019 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R44GM119906 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | 000 | 3 | NIH | 3/12/2019 | $475,637 |
| 2019 | 2019 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R43NS108847 | Resubmission: Systems for Exploring Pathogenicity in Clinical Variants of a Presynaptic Protein Involved in Epilepsy | 000 | 1 | NIH | 5/1/2019 | $224,703 |
| 2019 | 2019 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R43NS113691 | Function-based Variant Assessment of Epilepsome Genes to Increase Diagnostic Yield | 000 | 1 | NIH | 8/23/2019 | $664,094 |
| 2019 | 2016 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R43GM119906 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | 000 | 1 | NIH | 2/19/2019 | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $860,448 ) |
| 2018 | 2018 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R44GM119906 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | 000 | 2 | NIH | 3/21/2018 | $510,448 |
| 2018 | 2018 | NEMAMETRIX, INC | 44 W 7TH AVE | EUGENE | OR | 97401-2948 | LANE | USA | R43AG061978 | Testing Lifespan/Healthspan Pharmacological Interventions in Humanized C. elegans Knock-In Models of Dementia | 000 | 1 | NIH | 9/18/2018 | $350,000 |
|
 | Issue Date FY: 2017 ( Subtotal = -$165 ) |
| 2017 | 2014 | NEMAMETRIX, INC | 1724 SYLVAN ST | EUGENE | OR | 97403-2126 | LANE | USA | R43AG047020 | Microfluidic screening devices for health-span extending drugs | 000 | 1 | NIH | 2/28/2017 | -$165 |
|
 | Issue Date FY: 2016 ( Subtotal = $149,850 ) |
| 2016 | 2016 | NEMAMETRIX LLC | 1724 SYLVAN STREET | EUGENE | OR | 97403 | LANE | USA | R43GM119906 | Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms | 000 | 1 | NIH | 5/10/2016 | $149,850 |
|
 | Issue Date FY: 2015 ( Subtotal = $0 ) |
| 2015 | 2014 | NEMAMETRIX LLC | 1724 SYLVAN STREET | EUGENE | OR | 97403 | LANE | USA | R43AG047020 | Microfluidic screening devices for health-span extending drugs | 000 | 1 | NIH | 6/10/2015 | $0 |
|
 | Issue Date FY: 2014 ( Subtotal = $158,406 ) |
| 2014 | 2014 | NEMAMETRIX LLC | 1724 SYLVAN STREET | EUGENE | OR | 97403 | LANE | USA | R43AG047020 | Microfluidic screening devices for health-span extending drugs | 000 | 1 | NIH | 1/31/2014 | $158,406 |
|
|